Review
BibTex RIS Cite

Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri

Year 2018, Volume: 16 Issue: 2, 224 - 230, 05.08.2018
https://doi.org/10.24323/akademik-gida.449624

Abstract

Metabolik
sendrom (MetS), genetik ve çevresel etkenlerle gelişen abdominal obezite, dislipidemi,
hiperglisemi, protrombotik ve proinflamatuar durumlarla karakterize bir kardiyometabolik
risk faktörleri grubudur. Sedanter yaşam şekli ve bilinçsiz gıda tüketimi MetS’in
artışına neden olmaktadır ve günümüzde çocukluk, adölesan, yetişkin gibi her
yaş grubunda görülebilmektedir. Metabolik sendromun önlenmesinde ve tedavisinde
optimum beslenme ve sağlıklı yaşam en öncelikli ve etkili yaklaşımdır.
Gıdalarda doğal olarak bulunan biyoaktif gıda bileşenlerinin çeşitli
mekanizmalar ile özellikle MetS ile mücadelede etkili olduğu ifade edilmekte ve
MetS’in önlenmesinde yeni bir yaklaşım olarak çalışılmaktadır. Metabolik
sendromun sıklığının ülkemizde ve dünyada giderek artması, MetS’in önlenmesine
ilişkin ciddi ulusal ve uluslararası politikaların izlenmesi yönünde önemli
planlamalar yapılmasını gerektirmektedir. Bu derlemede, bazı gıdaların veya
gıdalarda bulunan bazı biyoaktif bileşenlerin metabolizmayı hızlandıran, enzim
inhibisyonu ile sindirim ve emilimi engelleyen, açlık ve tokluk mekanizmaları
üzerine etkilerini inceleyen araştırma sonuçlarının, MetS’i önleyen etkileri
ile değerlendirilmesi amaçlanmıştır.

References

  • [1] Arslan, M., Atmaca, A., Ayvaz, G. (2009). Metabolik Sendrom Kılavuzu. 2009. Erişim Tarihi: 04/10/2016. http://www.turkendokrin.org/files/pdf/metabolik_sendrom.pdf.
  • [2] Türk Kardiyoloji Derneği. (2015). Türkiye Metabolik Sendrom Araştırması. 21. Ulusal Kardiyoloji Kongres, 16-20 Kasım 2015, Antalya.
  • [3] Aguilar, M., Bhuket, T., Torres, S., Liu, B., Wong, RJ. (2015). Prevalence of the metabolic syndrome in the United States 2003–2012. JAMA, 313p.
  • [4] World Health Organization (WHO). (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation 1999. Part 1: Diagnosis and classification of diabetes mellitus. Erişim Tarihi: 11/07/2016. Geneva, Switzerland. 66p. http://apps.who.int/iris/handle/10665/66040.
  • [5] Gündogan, K., Bayram, F., Gedik, V., Kaya, A., Karaman, A., Demir, O., Sabuncu, T., Kocer, D., Coşkun, R. (2013). Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Science, 9(2), 243-253.
  • [6] Sönmez, A., Bayram, F., Barcin, C., Ozsan, M., Kaya, A., Gedik, V. (2013). Waist circumference cutoff points to predict obesity, metabolic syndrome, and cardiovascular risk in Turkish adults. International Journal of Endocrinology, Article ID 767202: 7p.
  • [7] Alberti, K.G., Zimmet, P.Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
  • [8] National Cholesterol Education Program. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
  • [9] Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-1062.
  • [10] Şendur, M.A.N., Güven, G. (2011). Metabolic sendroma güncel bakış. İç Hastalıkları Dergisi, 18, 125-131.
  • [11] Balcı, M.K. (2008). Metabolik sendrom. Türkiye Klinikleri Journal of Medical Sciences, 28(6 Suppl. 1), 102-106.
  • [12] TURDEP-II Study Group. (2011). Diabetes epidemic in Turkey: results of the second population-based survey of diabetes and risk characteristics in Turkey (TURDEP-II). Diabetologia 54(1):140. 46th General Assembly of the European Association for the Study of Diabetes (EASD); 2010 Sep 20-24; Stockholm, Sweden.
  • [13] Weaver, K.L., Ivester, P., Seeds, M., Case, D.L., Arm, J.P., Chilton, F.H. (2009). Effect of dietary fatty acids on inflammatory gene expression in healthy humans. Journal of Biological Chemistry, 284, 15400–7.
  • [14] Liu, C.T., Hse, H., Lii, C.K., Chen, P.S., Sheen, L.Y. (2005). Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats. European Journal of Pharmacology, 516, 165-173.
  • [15] DeVries, J.W. (2001). The definition of dietary fiber. Cereal Foods World, 46(3), 112-126.
  • [16] Lyly, M.M., Salmenkallio-Marttila, T., Suortti, K., Autio, K., Lahteenmaki, L. (2003). Influence of oat β -glucan preparations on the perception of mouthfeel and on rheological properties in beverage prototypes. Cereal Chemistry, 80(5), 536-541.
  • [17] Behall, K.M., Scholfield, D.J., Hallrisch, J. (2004). Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. American Journal of Clinical Nutrition, 80(5), 1185-1193.
  • [18] Kris-Etherton, P.M., Hu, F.B., Ros, E., Sabate, J. (2008). The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. Journal of Nutrition, 138, 1746-1751.
  • [19] Zeng, Y., Pu, X., Du, J., Yang, S., Yang, T., Jia, P. (2012). Use of functional foods for diabetes prevention in China. African Journal of Pharmacology, 6, 2570-2579.
  • [20] Berg, A.H., Combs, T.P., Scherer, P.E. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism, 13, 84-89.
  • [21] Diabetes Prevention Program Research Group. (2002). Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
  • [22] Balkan, F. (2013). Metabolik sendrom. Ankara Medical Journal, 13(2), 85-90.
  • [23] Willett, W.C., Sacks, F., Trichopolou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E. (1995). Mediterranean diet pyramid: a cultural model for healthy eating. American Journal of Clinical Nutrition, 61(6 Suppl), 1402-1406.
  • [24] Minehira, K., Tappy, L. (2002). Dietary and lifestyle interventions in the management of metabolic syndrome; present status and future perspective. European Journal of Clinical Nutrition, 56, 1262-9.
  • [25] Zemel, M.B., Thompson, W., Milstead, A., Morris, K., Campbell, P. (2004). Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obesity Research, 12(4), 582-590.
  • [26] Zemel, M.B., Richards, J., Milstead, A., Campbell, P. (2005). Effects of calcium and dairy on body composition and weight loss in African American adults. Obesity Research, 13(7), 1218-1225.
  • [27] Özdemir, G., Çelebi, F. (2011). Kalsiyum ve ağırlık kontrolü. Uluslararası İnsan Bilimleri Dergisi, 8(2), 643-652.
  • [28] Brennan, C.S., Cleary, L.J. (2005). The potential use of cereal (1→3,1→4)-β-D-glucans as functional food ingredients. Journal of Cereal Science, 42(1), 1-13.
  • [29] Altun, B., Arici, M., Nergizoğlu, G., Derici, U., Karatan, O., Turgan, C. (2005). Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. Journal of Hypertension, 23(10), 1817-23.
  • [30] Ni, M.C., Dunshea-Mooij, C.A., Bennett, D., Rodgers, A. (2005). Chitosan for overweight or obesity. Cochrane Database of Systematic Review, 3, CD003892.
  • [31] Adak, M., Shivapuri, J.N. (2010). Serum lipid and lipoprotein profile abnormality in predicting the risk of coronary artery disease in nondiabetic patients attending NMCTH, Birgunj. Nepal Medical College Journal, 12(3), 158-164.
  • [32] Jin, K.P., Sook, M.S. (2007). Nutrient intakes and serum lipid profiles are improved in elderly Korean women with home food delivery. Nutrition Research, 27, 78-85.
  • [33] Frontera, W.R., Suh, D., Krivickas, L.S. (2000). Skeletal muscle fiber quality in older men and women. Am J Cell Physiology, 279, 611-618.
  • [34] Trigueros, L., Peña, S., Ugidos, A.V., Sayas-Barberá, E., Pérez-Álvarez, J.A., Sendra, E. (2013). Food ingredients as anti-obesity agents: a review. Critical Reviews in Food Science and Nutrition, 53/9(929-42), 1040-8398.
  • [35] Trigueros, L, Sendra, E. (2015). Fatty acid and conjugated linoleic acid (CLA) content in fermented milks as assessed by direct methylation. LWT - Food Science and Technology, 60(1), 315-319.
  • [36] Julia, M.W., Cyril, W.C.K., Russell-de, S., Azadeh, E., Augustine M. (2010). The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism Journal, 59, 1331-1340.
  • [37] Ho, J.N., Choi, J.W., Lim, W.C., Kim, M.K., Lee, I.Y., Cho, H.Y. (2013). Kefir inhibits 3T3-L1 adipocyte differentiation through down-regulation of adipogenic transcription factor expression. Journal of the Science of Food and Agriculture, 93(3), 485-490.
  • [38] Chen, H.L., Tung, Y.T., Tsai, C.T., Lai, C.Z., Lai, Z.L., Tsai, H.C., Lin, Y.L., Wang, C.H., Chen, C.M. (2014). Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. International Journal of Obesity, 38(9), 1172-1179.
  • [39] Ercan, P., El, S.N. (2014). Obeziteyi önleyen gıda bileşenleri. Akademik Gıda, 12(1), 69-77.
  • [40] Poppitt, S.D., Van, D.J.D., McGill, A.T., Mulvey, T.B., Leahy, F.E. (2007). Supplementation of a high-carbohydrate breakfast with barley beta glucan improves postprandial glycemic response for meals but not beverages. Asia Pacific Journal of Clinical Nutrition, 16, 16-24.
  • [41] Queenan, K.M., Stewart, M.L., Smith, K.N., Thomas, W., Fulcher, R.G., Slavin, J.L. (2007). Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutrition Journal, 6, 6-12.
  • [42] Amani, R.A., Baghdadchi, J.B., Zand-Moghaddam, A.A. (2005). Effects of soy protein isoflavones on serum lipids, lipoprotein profile and serum glucose of hypercholesterolemic rabbits. International Journal of Endocrinology and Metabolism, 2, 87-92.
  • [43] Lewis, N.M., Seburg, S., Flanagan, N.L. (2000). Enriched eggs as a source of n-3 polyunsaturated fatty acids for humans. Poultry Science, 79, 971-974.
  • [44] Rhee, K.S., Kim, E.S., Kim, B.K., Jung, B.M., Rhee, K.C. (2004). Extrusion of minced catfish with corn and defatted soy flours for snack foods. Journal of Food Processing and Preservation, 28, 288-301.
  • [45] Belay, A., Ture, K., Redi, M., Asfaw, A. (2008). Measurement of caffeine in coffee beans with UV/vis spectrometer. Food Chemistry, 108, 310-315.
  • [46] Sacks, F.M., Svetkey, L.P., Vollmer, W.M. (2001). Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. New England Journal of Medicine, 344, 3-10.
  • [47] Kromhout, D., Giltay, E.J., Geleijnse, J.M. (2010). Omega-3 fatty acids and cardiovascular events after myocardial infarction. New England Journal of Medicine, 363, 2015-2026.
  • [48] Yokoyama, M., Origasa, H., Matsuzaki, M. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 369, 1090-1098.
  • [49] Ajani, U.A., Ford, E.S., Mokdad, A.H. (2004). Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. Journal of Nutrition, 134, 1181-1185.
  • [50] Hodgson, J.M., Burke, V., Beilin, L.J., Puddey, I.B. (2006). Partial substitution of carbohydrate intake with protein intake from lean red meat lowers blood pressure in hypertensive persons. American Journal of Clinical Nutrition, 83, 780-787.
  • [51] King, D.E., Egan, B.M., Woolson, R.F., Mainous, A.G., Al-Solaiman, Y., Jesri, A. (2007). Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Medicine, 167, 502-506.
  • [52] Yu, Y., Hu, J.N., Miyaguchi, Y.J., Bai, X.F., Du, Y.G., Lin, B.C. (2006). Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides, 11, 29-40.
  • [53] Khan, M.I., Anjum, F.M., Sohaib, M., Sameen, A. (2013). Tackling metabolic syndrome by functional foods. Reviews in Endocrine and Metabolic Disorders, 14, 287-297.
  • [54] Mottillo, S., Filion, K., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Ernesto, R., Shiffrin, M.D., Mark, J., Eisenberg, M.D. (2010). The metabolic syndrome and cardiovascular risk. Journal of the American College of Cardiology, 56(14), 1113-1132.

Effect of Bioactive Food Components on Metabolic Syndrome

Year 2018, Volume: 16 Issue: 2, 224 - 230, 05.08.2018
https://doi.org/10.24323/akademik-gida.449624

Abstract

Metabolic syndrome (MetS) is a group of
cardiometabolic risk factors characterized by abdominal obesity, dyslipidemia,
hyperglycaemia, prothrombotic and proinflammatory conditions that develop with genetic
and environmental factors. Sedentary lifestyle and unconscious consumption of
food leads to an increase in the metabolic syndrome. Today, MetS can be seen in
all age groups such as childhood, adolescent and adults. Optimal nutrition and healthy
lifestyle are the most important and effective approach in the prevention and
treatment of MetS. It is stated that bioactive food components naturally found
in naturally in foods are effective for combating against MetS especially with
various mechanisms and being studied as a new approach in the prevention of MetS.
The increasing prevalence of MetS in the world and our country requires
significant planning towards the monitoring of serious national and
international policies for the prevention of the disease. In this review, it is
aimed to evaluate the results of some bioactive compounds found in foods which
prevent digestion and absorption by the inhibition of the enzyme, some of the
food accelerates the hunger and satiety mechanisms effects to evaluate the
results of research with MetS inhibiting effects.

References

  • [1] Arslan, M., Atmaca, A., Ayvaz, G. (2009). Metabolik Sendrom Kılavuzu. 2009. Erişim Tarihi: 04/10/2016. http://www.turkendokrin.org/files/pdf/metabolik_sendrom.pdf.
  • [2] Türk Kardiyoloji Derneği. (2015). Türkiye Metabolik Sendrom Araştırması. 21. Ulusal Kardiyoloji Kongres, 16-20 Kasım 2015, Antalya.
  • [3] Aguilar, M., Bhuket, T., Torres, S., Liu, B., Wong, RJ. (2015). Prevalence of the metabolic syndrome in the United States 2003–2012. JAMA, 313p.
  • [4] World Health Organization (WHO). (1999). Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation 1999. Part 1: Diagnosis and classification of diabetes mellitus. Erişim Tarihi: 11/07/2016. Geneva, Switzerland. 66p. http://apps.who.int/iris/handle/10665/66040.
  • [5] Gündogan, K., Bayram, F., Gedik, V., Kaya, A., Karaman, A., Demir, O., Sabuncu, T., Kocer, D., Coşkun, R. (2013). Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Science, 9(2), 243-253.
  • [6] Sönmez, A., Bayram, F., Barcin, C., Ozsan, M., Kaya, A., Gedik, V. (2013). Waist circumference cutoff points to predict obesity, metabolic syndrome, and cardiovascular risk in Turkish adults. International Journal of Endocrinology, Article ID 767202: 7p.
  • [7] Alberti, K.G., Zimmet, P.Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
  • [8] National Cholesterol Education Program. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497.
  • [9] Alberti, K.G.M., Zimmet, P., Shaw, J. (2005). The metabolic syndrome-a new worldwide definition. Lancet, 366, 1059-1062.
  • [10] Şendur, M.A.N., Güven, G. (2011). Metabolic sendroma güncel bakış. İç Hastalıkları Dergisi, 18, 125-131.
  • [11] Balcı, M.K. (2008). Metabolik sendrom. Türkiye Klinikleri Journal of Medical Sciences, 28(6 Suppl. 1), 102-106.
  • [12] TURDEP-II Study Group. (2011). Diabetes epidemic in Turkey: results of the second population-based survey of diabetes and risk characteristics in Turkey (TURDEP-II). Diabetologia 54(1):140. 46th General Assembly of the European Association for the Study of Diabetes (EASD); 2010 Sep 20-24; Stockholm, Sweden.
  • [13] Weaver, K.L., Ivester, P., Seeds, M., Case, D.L., Arm, J.P., Chilton, F.H. (2009). Effect of dietary fatty acids on inflammatory gene expression in healthy humans. Journal of Biological Chemistry, 284, 15400–7.
  • [14] Liu, C.T., Hse, H., Lii, C.K., Chen, P.S., Sheen, L.Y. (2005). Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats. European Journal of Pharmacology, 516, 165-173.
  • [15] DeVries, J.W. (2001). The definition of dietary fiber. Cereal Foods World, 46(3), 112-126.
  • [16] Lyly, M.M., Salmenkallio-Marttila, T., Suortti, K., Autio, K., Lahteenmaki, L. (2003). Influence of oat β -glucan preparations on the perception of mouthfeel and on rheological properties in beverage prototypes. Cereal Chemistry, 80(5), 536-541.
  • [17] Behall, K.M., Scholfield, D.J., Hallrisch, J. (2004). Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. American Journal of Clinical Nutrition, 80(5), 1185-1193.
  • [18] Kris-Etherton, P.M., Hu, F.B., Ros, E., Sabate, J. (2008). The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. Journal of Nutrition, 138, 1746-1751.
  • [19] Zeng, Y., Pu, X., Du, J., Yang, S., Yang, T., Jia, P. (2012). Use of functional foods for diabetes prevention in China. African Journal of Pharmacology, 6, 2570-2579.
  • [20] Berg, A.H., Combs, T.P., Scherer, P.E. (2002). ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends in Endocrinology and Metabolism, 13, 84-89.
  • [21] Diabetes Prevention Program Research Group. (2002). Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403.
  • [22] Balkan, F. (2013). Metabolik sendrom. Ankara Medical Journal, 13(2), 85-90.
  • [23] Willett, W.C., Sacks, F., Trichopolou, A., Drescher, G., Ferro-Luzzi, A., Helsing, E. (1995). Mediterranean diet pyramid: a cultural model for healthy eating. American Journal of Clinical Nutrition, 61(6 Suppl), 1402-1406.
  • [24] Minehira, K., Tappy, L. (2002). Dietary and lifestyle interventions in the management of metabolic syndrome; present status and future perspective. European Journal of Clinical Nutrition, 56, 1262-9.
  • [25] Zemel, M.B., Thompson, W., Milstead, A., Morris, K., Campbell, P. (2004). Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obesity Research, 12(4), 582-590.
  • [26] Zemel, M.B., Richards, J., Milstead, A., Campbell, P. (2005). Effects of calcium and dairy on body composition and weight loss in African American adults. Obesity Research, 13(7), 1218-1225.
  • [27] Özdemir, G., Çelebi, F. (2011). Kalsiyum ve ağırlık kontrolü. Uluslararası İnsan Bilimleri Dergisi, 8(2), 643-652.
  • [28] Brennan, C.S., Cleary, L.J. (2005). The potential use of cereal (1→3,1→4)-β-D-glucans as functional food ingredients. Journal of Cereal Science, 42(1), 1-13.
  • [29] Altun, B., Arici, M., Nergizoğlu, G., Derici, U., Karatan, O., Turgan, C. (2005). Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. Journal of Hypertension, 23(10), 1817-23.
  • [30] Ni, M.C., Dunshea-Mooij, C.A., Bennett, D., Rodgers, A. (2005). Chitosan for overweight or obesity. Cochrane Database of Systematic Review, 3, CD003892.
  • [31] Adak, M., Shivapuri, J.N. (2010). Serum lipid and lipoprotein profile abnormality in predicting the risk of coronary artery disease in nondiabetic patients attending NMCTH, Birgunj. Nepal Medical College Journal, 12(3), 158-164.
  • [32] Jin, K.P., Sook, M.S. (2007). Nutrient intakes and serum lipid profiles are improved in elderly Korean women with home food delivery. Nutrition Research, 27, 78-85.
  • [33] Frontera, W.R., Suh, D., Krivickas, L.S. (2000). Skeletal muscle fiber quality in older men and women. Am J Cell Physiology, 279, 611-618.
  • [34] Trigueros, L., Peña, S., Ugidos, A.V., Sayas-Barberá, E., Pérez-Álvarez, J.A., Sendra, E. (2013). Food ingredients as anti-obesity agents: a review. Critical Reviews in Food Science and Nutrition, 53/9(929-42), 1040-8398.
  • [35] Trigueros, L, Sendra, E. (2015). Fatty acid and conjugated linoleic acid (CLA) content in fermented milks as assessed by direct methylation. LWT - Food Science and Technology, 60(1), 315-319.
  • [36] Julia, M.W., Cyril, W.C.K., Russell-de, S., Azadeh, E., Augustine M. (2010). The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism Journal, 59, 1331-1340.
  • [37] Ho, J.N., Choi, J.W., Lim, W.C., Kim, M.K., Lee, I.Y., Cho, H.Y. (2013). Kefir inhibits 3T3-L1 adipocyte differentiation through down-regulation of adipogenic transcription factor expression. Journal of the Science of Food and Agriculture, 93(3), 485-490.
  • [38] Chen, H.L., Tung, Y.T., Tsai, C.T., Lai, C.Z., Lai, Z.L., Tsai, H.C., Lin, Y.L., Wang, C.H., Chen, C.M. (2014). Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. International Journal of Obesity, 38(9), 1172-1179.
  • [39] Ercan, P., El, S.N. (2014). Obeziteyi önleyen gıda bileşenleri. Akademik Gıda, 12(1), 69-77.
  • [40] Poppitt, S.D., Van, D.J.D., McGill, A.T., Mulvey, T.B., Leahy, F.E. (2007). Supplementation of a high-carbohydrate breakfast with barley beta glucan improves postprandial glycemic response for meals but not beverages. Asia Pacific Journal of Clinical Nutrition, 16, 16-24.
  • [41] Queenan, K.M., Stewart, M.L., Smith, K.N., Thomas, W., Fulcher, R.G., Slavin, J.L. (2007). Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutrition Journal, 6, 6-12.
  • [42] Amani, R.A., Baghdadchi, J.B., Zand-Moghaddam, A.A. (2005). Effects of soy protein isoflavones on serum lipids, lipoprotein profile and serum glucose of hypercholesterolemic rabbits. International Journal of Endocrinology and Metabolism, 2, 87-92.
  • [43] Lewis, N.M., Seburg, S., Flanagan, N.L. (2000). Enriched eggs as a source of n-3 polyunsaturated fatty acids for humans. Poultry Science, 79, 971-974.
  • [44] Rhee, K.S., Kim, E.S., Kim, B.K., Jung, B.M., Rhee, K.C. (2004). Extrusion of minced catfish with corn and defatted soy flours for snack foods. Journal of Food Processing and Preservation, 28, 288-301.
  • [45] Belay, A., Ture, K., Redi, M., Asfaw, A. (2008). Measurement of caffeine in coffee beans with UV/vis spectrometer. Food Chemistry, 108, 310-315.
  • [46] Sacks, F.M., Svetkey, L.P., Vollmer, W.M. (2001). Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. New England Journal of Medicine, 344, 3-10.
  • [47] Kromhout, D., Giltay, E.J., Geleijnse, J.M. (2010). Omega-3 fatty acids and cardiovascular events after myocardial infarction. New England Journal of Medicine, 363, 2015-2026.
  • [48] Yokoyama, M., Origasa, H., Matsuzaki, M. (2007). Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 369, 1090-1098.
  • [49] Ajani, U.A., Ford, E.S., Mokdad, A.H. (2004). Dietary fiber and C-reactive protein: findings from national health and nutrition examination survey data. Journal of Nutrition, 134, 1181-1185.
  • [50] Hodgson, J.M., Burke, V., Beilin, L.J., Puddey, I.B. (2006). Partial substitution of carbohydrate intake with protein intake from lean red meat lowers blood pressure in hypertensive persons. American Journal of Clinical Nutrition, 83, 780-787.
  • [51] King, D.E., Egan, B.M., Woolson, R.F., Mainous, A.G., Al-Solaiman, Y., Jesri, A. (2007). Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Medicine, 167, 502-506.
  • [52] Yu, Y., Hu, J.N., Miyaguchi, Y.J., Bai, X.F., Du, Y.G., Lin, B.C. (2006). Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin. Peptides, 11, 29-40.
  • [53] Khan, M.I., Anjum, F.M., Sohaib, M., Sameen, A. (2013). Tackling metabolic syndrome by functional foods. Reviews in Endocrine and Metabolic Disorders, 14, 287-297.
  • [54] Mottillo, S., Filion, K., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Ernesto, R., Shiffrin, M.D., Mark, J., Eisenberg, M.D. (2010). The metabolic syndrome and cardiovascular risk. Journal of the American College of Cardiology, 56(14), 1113-1132.
There are 54 citations in total.

Details

Primary Language Turkish
Subjects Food Engineering
Journal Section Review Papers
Authors

Gülçin Şatır 0000-0003-1862-6434

Publication Date August 5, 2018
Submission Date May 29, 2017
Published in Issue Year 2018 Volume: 16 Issue: 2

Cite

APA Şatır, G. (2018). Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri. Akademik Gıda, 16(2), 224-230. https://doi.org/10.24323/akademik-gida.449624
AMA Şatır G. Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri. Akademik Gıda. August 2018;16(2):224-230. doi:10.24323/akademik-gida.449624
Chicago Şatır, Gülçin. “Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri”. Akademik Gıda 16, no. 2 (August 2018): 224-30. https://doi.org/10.24323/akademik-gida.449624.
EndNote Şatır G (August 1, 2018) Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri. Akademik Gıda 16 2 224–230.
IEEE G. Şatır, “Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri”, Akademik Gıda, vol. 16, no. 2, pp. 224–230, 2018, doi: 10.24323/akademik-gida.449624.
ISNAD Şatır, Gülçin. “Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri”. Akademik Gıda 16/2 (August 2018), 224-230. https://doi.org/10.24323/akademik-gida.449624.
JAMA Şatır G. Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri. Akademik Gıda. 2018;16:224–230.
MLA Şatır, Gülçin. “Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri”. Akademik Gıda, vol. 16, no. 2, 2018, pp. 224-30, doi:10.24323/akademik-gida.449624.
Vancouver Şatır G. Metabolik Sendromla Mücadelede Biyoaktif Gıda Bileşenlerinin Etkileri. Akademik Gıda. 2018;16(2):224-30.

25964   25965    25966      25968   25967


88x31.png

Bu eser Creative Commons Atıf-GayriTicari 4.0 (CC BY-NC 4.0) Uluslararası Lisansı ile lisanslanmıştır.

Akademik Gıda (Academic Food Journal) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).